Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of the combination of vemurafenib
with cobimetinib in patients with active melanoma brain metastases.